Month: September 2012

Greater Illness Risk in Caregivers and Neurologic Patients with PBA, Study Says

Avanir Pharmaceuticals recently announced in a news release that a survey conducted by Harris Interactive, indicates that in a variety of neurologic patient populations including stroke, traumatic brain injury (TBI), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), pseudobulbar affect (PBA) symptoms may be linked to a considerable burden of illness among PBA patients and primary caregivers.

Read More